Hancock Jaffe Laboratories Inc P/E
Cos'è P/E di Hancock Jaffe Laboratories Inc?
P/E di Hancock Jaffe Laboratories Inc è 0.00
Qual è la definizione di P/E?
Il rapporto prezzo / utili è il rapporto tra il prezzo delle azioni di una società e l'utile per azione della società calcolato su dodici mesi.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/E di aziende nel Health Care settore su NASDAQ rispetto a Hancock Jaffe Laboratories Inc
Cosa fa Hancock Jaffe Laboratories Inc?
Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.
Aziende con p/e simili a Hancock Jaffe Laboratories Inc
- Richland Resources International ha P/E di N/A
- Safeplus International ha P/E di N/A
- China Yanyuan Yuhui Natl Ed Grp ha P/E di N/A
- Acusphere ha P/E di N/A
- American Oriental Bioengineering ha P/E di N/A
- Gourmet Provisions International ha P/E di N/A
- Hancock Jaffe Laboratories Inc ha P/E di 0.00
- SEL Manufacturing ha P/E di 0.00
- China Zhong Qi Hldgs ha P/E di 0.00
- MedSmart ha P/E di 0.00
- Panbela Therapeutics ha P/E di 0.00
- Epic ha P/E di 0.00
- 2574 ha P/E di 0.00